The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(benzyloxy)-N-cyclohexylbenzamide ID: ALA4474604
PubChem CID: 4946354
Max Phase: Preclinical
Molecular Formula: C20H23NO2
Molecular Weight: 309.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1CCCCC1)c1ccccc1OCc1ccccc1
Standard InChI: InChI=1S/C20H23NO2/c22-20(21-17-11-5-2-6-12-17)18-13-7-8-14-19(18)23-15-16-9-3-1-4-10-16/h1,3-4,7-10,13-14,17H,2,5-6,11-12,15H2,(H,21,22)
Standard InChI Key: KDQYEQMHLSVUQW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
33.5777 -2.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5766 -3.5393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2846 -3.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9943 -3.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9914 -2.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2828 -2.3109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6976 -2.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4069 -2.7109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6945 -1.4878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1130 -2.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8207 -2.7089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5264 -2.2984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5237 -1.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8095 -1.0746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1068 -1.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7026 -3.9464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7039 -4.7635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4123 -5.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4089 -5.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1165 -6.3930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8245 -5.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8206 -5.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1125 -4.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 10 1 0
4 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.41Molecular Weight (Monoisotopic): 309.1729AlogP: 4.33#Rotatable Bonds: 5Polar Surface Area: 38.33Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.41CX LogD: 4.41Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.89Np Likeness Score: -1.00
References 1. Li Y, Huang T, Lou B, Ye D, Qi X, Li X, Hu S, Ding T, Chen Y, Cao Y, Mo M, Dong J, Wei M, Chu Y, Li H, Jiang XC, Cheng N, Zhou L.. (2019) Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor., 163 [PMID:30580239 ] [10.1016/j.ejmech.2018.12.028 ]